, Tracking Stock Market Picks
Enter Symbol:
Hanger Orthopedic Group, Inc. (HGR) [hlAlert]

down 25.97 %

Hanger Orthopedic Group, Inc. (HGR) rated Overweight with price target $28 by Barclays

Posted on: Thursday,  May 3, 2012  12:25 PM ET by Barclays

Barclays rated Overweight Hanger Orthopedic Group, Inc. (NYSE: HGR) on 05/03/2012, when the stock price was $23.87. Since
then, Hanger Orthopedic Group, Inc. has lost 25.97% as of 01/07/2016's recent price of $17.67.
If you would have followed this Barclays's recommendation on HGR, you would have lost 25.97% of your investment in 1344 days.

Hanger Orthopedic Group Inc. owns and operates orthotic and prosthetic (O&P) patient-care centers in the United States. Hanger Orthopedic Group, through its wholly owned subsidiary, Southern Prosthetic Supply, Inc. (SPS), distributes branded and private label O&P devices and components in the United States, all of which are manufactured by third parties. The Company also creates new products, through its wholly owned subsidiary, Innovative Neurotronics, Inc. (IN Inc.) for patients who have had a loss of mobility due to strokes, multiple sclerosis or other similar conditions. In May 2009, the Company acquired Northwest Prosthetic & Orthotic Clinic and Inline Orthotic and Prosthetic Systems. In October 2009, Hanger Orthopedic Group Inc. acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/3/2012 12:25 PM Buy
23.87 28.00
as of 12/31/2012
1 Week down  -0.40 %
1 Month up  4.78 %
3 Months down  -4.10 %
1 YTD up  14.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy